The Modi governmen should encourage Indian pharma industry to have the slogan “Discover in India” and not “Made in India ” uIntroduce a tough auditing system as is being done by many regulators in developed countries.
- Introduce single ministry instead of two ministries
- Introduction of E-governance in the correct spirit
- Encourage complimentary medicines like Homeopathy, Unani, Ayurveda, etc.
- Industry should support the government for segments like HIV/AIDS, TB, malaria, cancer etc. with special rates
- Stakeholders should be involved in all policy related government committees
- Prove that the government is working in a really transparent way and adhere to a strict time frame for each clearance.
- Bring it to the notice of the world that India is the cheapest producer of good quality, efficacious medicines
- Encourage industry to invest in R&D which should be treated as a part of the CSR obligation.
- Put sincere efforts to revive MSME units which were closed down over a period. Out of 10000 manufacturing units in the country, more than 75 per cent are in the MSME segment.
- Restructure the tax system. Pharma industry faces so many taxes at present and many government department/agencies are controlling it. There should be a single window system in the real sense.
- Encourage cluster system and set up mega pharma towns like Vizag and those found in China.
- Remove disparity in excise of bulk drugs and formulation
- Instead of price control, government should have a good monitoring system. China has recently withdrawn control on medicines to avoid shortage of life saving drugs
- Educate the common man that the pharma is not a commodity industry but a lifesaving industry. Cost is secondary and life is primary.
- Utilise the huge infrastructure of PSU units through the PPP system.’
- Set up state owned institutes like AIIMS in all states.
- Government should work as a facilitator and not as a regulator. Make a think tank of industry experts to help the government in improving the volume, exports, and development of new molecules
- Encourage insurance for the common man so that there is no direct burden on the government for the treatment of patients and to increase budget allocation for health.
– BR Sikri, Vice President, BDMA, Vice President, IDMA
